Biodesix

BDSX · NASDAQ

$23.87+$0.47 (+2.01%)TodayMarket closed ·
Prev close $23.40

Latest news

  • News

    Biodesix Adds AI-Powered Imaging Test To Expand Lung Cancer Risk Screening

  • Press releaseGlobe Newswire

    Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkers

  • Press releaseGlobe Newswire

    Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings

  • Press releaseGlobe Newswire

    Biodesix to Participate in Canaccord Genuity’s 46th Annual Growth Conference

  • Press releaseGlobe Newswire

    Biodesix to Participate in Upcoming Investor Conferences

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    Biodesix Q1 2026 Earnings Call: Complete Transcript

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • News

    Earnings Scheduled For May 4, 2026

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releaseGlobe Newswire

    Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development

  • News

    Biodesix Earnings Report: Q4 Overview

  • News

    Earnings Scheduled For February 26, 2026

  • Press releaseGlobe Newswire

    Biodesix to Participate in Upcoming Investor Conferences

  • News

    Market-Moving News for January 12th

  • News

    12 Health Care Stocks Moving In Monday's After-Market Session

  • News

    Earnings Scheduled For November 3, 2025

  • News

    What's Next: Biodesix's Earnings Preview

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

  • Press releaseGlobe Newswire

    Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays

  • Press releaseGlobe Newswire

    Biodesix Announces One-for-Twenty Reverse Stock Split

  • NewsRishabh Mishra

    Stock Market Today: Dow Futures Slip, Nasdaq Rises As Trump Files Tariff Appeal—American Eagle, Salesforce, Lululemon In Focus (UPDATED)

  • NewsAvi Kapoor

    Why American Eagle Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releaseGlobe Newswire

    Biodesix Recognized as a Thermo Fisher Scientific Center of Excellence (COE) for NGS Diagnostics

  • Press releaseGlobe Newswire

    Biodesix to Present at the Canaccord Genuity 45th Annual Growth Conference

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • Press releaseGlobe Newswire

    Biodesix to Participate in Upcoming Investor Conferences

  • NewsAvi Kapoor

    Why Toll Brothers Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • News

    Biodesix Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Press releaseGlobe Newswire

    Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • NewsRishabh Mishra

    US Futures Tumble As Traders Await Trump's Congress Address: 'Volatility Is Certainly Being Fed By Trump 2.0 Moves,' Says Expert

  • Press releaseGlobe Newswire

    Biodesix to Present at TD Cowen 45th Annual Health Care Conference

  • Press releaseGlobe Newswire

    Biodesix to Participate in Three Investor Conferences in November

  • Press releaseBusiness Wire

    Biodesix to Report Third Quarter 2024 Financial Results on November 1, 2024

  • Press releaseBusiness Wire

    Biodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical Study

  • NewsAvi Kapoor

    Why Phoenix Motor Shares Are Trading Higher By 150%; Here Are 20 Stocks Moving Premarket

  • Press releaseBusiness Wire

    Biodesix to Present at Two Investor Conferences in September

  • Press releaseBusiness Wire

    Biodesix Announces Second Quarter 2024 Results and Highlights

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.